This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
OK
Dublin: 20 °C Monday 23 July, 2018
Advertisement

Dublin scientist awarded €250k grant for breast cancer research

Dr Alex von Kriegsheim based at UCD will investigate the role a small protein called ‘ISG15’ plays.

Breast cancer cells separating
Breast cancer cells separating
Image: Shutterstock

A DUBLIN SCIENTIST has been awarded a grant worth around £200,000 (€252,000) by research charity Breast Cancer Campaign to study what role a small protein plays in the early stages of breast cancer spread.

Little is known about how breast cancer cells start to spread. In some patients, breast cancer cells undergo a transition, enabling them to become more mobile and spread throughout the body.

UCD

Dr Alex von Kriegsheim, based at University College Dublin, previously found that forcing normal cells to overproduce a small protein called ‘ISG15’ causes these cells to undergo this transition and so behave more like cancer cells.

He currently studying in detail how this happens and whether breast cancer relies on the ISG15 protein to spread through the body.

This grant will allow Dr von Kriegsheim to create computer simulations to study how ISG15 is involved in the early stages of breast cancer spread.

The findings of the research could lead to drugs being developed that block ISG15’s activity and the proteins it works with.

Every year, 2,700 women in the Republic of Ireland are diagnosed with breast cancer, with 700 women dying each year.

Read: Seriously ill 4-year-old Gavin undergoes lifesaving cancer surgery in Texas>

Read: 49 cyclists, 700km and one very good cause>

  • Share on Facebook
  • Email this article
  •  

Read next:

COMMENTS (5)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

Leave a commentcancel